AUPH Annual Accounts Payable
$4.33 M
+$1.24 M+40.17%
31 December 2023
Summary:
As of January 21, 2025, AUPH annual accounts payable is $4.33 million, with the most recent change of +$1.24 million (+40.17%) on December 31, 2023. During the last 3 years, it has risen by +$1.69 million (+64.21%). AUPH annual accounts payable is now -15.23% below its all-time high of $5.10 million, reached on December 31, 2003.AUPH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUPH Quarterly Accounts Payable
$8.88 M
+$463.00 K+5.50%
30 September 2024
Summary:
As of January 21, 2025, AUPH quarterly accounts payable is $8.88 million, with the most recent change of +$463.00 thousand (+5.50%) on September 30, 2024. Over the past year, it has increased by +$463.00 thousand (+5.50%). AUPH quarterly accounts payable is now at all-time high.AUPH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUPH Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.2% | +5.5% |
| 3 y3 years | +64.2% | - |
| 5 y5 years | +46.6% | - |
AUPH Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.2% | at high | +187.6% |
| 5 y | 5-year | at high | +64.2% | at high | +306.9% |
| alltime | all time | -15.2% | +1050.5% | at high | +2260.5% |
Aurinia Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.88 M(+5.5%) |
| June 2024 | - | $8.41 M(+48.4%) |
| Mar 2024 | - | $5.67 M(+31.1%) |
| Dec 2023 | $4.33 M(+40.2%) | $4.33 M(-51.1%) |
| Sept 2023 | - | $8.85 M(+84.2%) |
| June 2023 | - | $4.81 M(+30.7%) |
| Mar 2023 | - | $3.68 M(+19.2%) |
| Dec 2022 | $3.09 M(-20.4%) | $3.09 M(-5.5%) |
| Mar 2022 | - | $3.27 M(-15.8%) |
| Dec 2021 | $3.88 M(+47.2%) | $3.88 M(+18.9%) |
| Sept 2021 | - | $3.26 M(+28.7%) |
| June 2021 | - | $2.54 M(+16.2%) |
| Mar 2021 | - | $2.18 M(-17.2%) |
| Dec 2020 | $2.63 M(-36.6%) | $2.63 M(-36.6%) |
| Dec 2019 | $4.15 M(+40.7%) | $4.15 M(+40.7%) |
| Dec 2018 | $2.95 M(-21.8%) | $2.95 M(-21.8%) |
| Dec 2017 | $3.77 M(+31.8%) | $3.77 M(+31.8%) |
| Dec 2016 | $2.86 M(+37.7%) | $2.86 M(+37.7%) |
| Dec 2015 | $2.08 M(+49.4%) | $2.08 M(+49.4%) |
| Dec 2014 | $1.39 M(+26.0%) | $1.39 M(+26.0%) |
| Dec 2013 | $1.10 M(-5.2%) | $1.10 M(+3.1%) |
| Sept 2013 | - | $1.07 M(-57.3%) |
| June 2013 | - | $2.51 M(+21.3%) |
| Mar 2013 | - | $2.07 M(+77.7%) |
| Dec 2012 | $1.17 M(+209.8%) | $1.17 M(-60.6%) |
| Sept 2012 | - | $2.95 M(+685.6%) |
| Dec 2011 | $376.10 K(-88.5%) | $376.10 K(-89.5%) |
| Sept 2008 | - | $3.59 M(-23.6%) |
| June 2008 | - | $4.69 M(+18.3%) |
| Mar 2008 | - | $3.97 M(-36.9%) |
| Sept 2007 | - | $6.29 M(-16.9%) |
| June 2007 | - | $7.57 M(+53.5%) |
| Mar 2007 | - | $4.93 M(+50.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $3.27 M(-32.7%) | $3.27 M(-21.5%) |
| Sept 2006 | - | $4.17 M(+36.1%) |
| June 2006 | - | $3.06 M(-28.7%) |
| Mar 2006 | - | $4.30 M(-11.6%) |
| Dec 2005 | $4.86 M(+28.4%) | $4.86 M(+48.1%) |
| Sept 2005 | - | $3.28 M(+26.3%) |
| June 2005 | - | $2.60 M(+7.7%) |
| Mar 2005 | - | $2.41 M(-36.2%) |
| Dec 2004 | $3.79 M(-25.8%) | $3.79 M(+12.3%) |
| Sept 2004 | - | $3.37 M(+31.6%) |
| June 2004 | - | $2.56 M(-47.4%) |
| Mar 2004 | - | $4.87 M(-4.6%) |
| Dec 2003 | $5.10 M(+129.8%) | $5.10 M(+43.6%) |
| Sept 2003 | - | $3.55 M(+9.4%) |
| June 2003 | - | $3.25 M(+18.1%) |
| Mar 2003 | - | $2.75 M(+23.8%) |
| Dec 2002 | $2.22 M(+34.5%) | $2.22 M(-21.9%) |
| Sept 2002 | - | $2.84 M(-26.9%) |
| June 2002 | - | $3.89 M(+144.1%) |
| Mar 2002 | - | $1.59 M(-59.9%) |
| Dec 2001 | $1.65 M(+49.7%) | - |
| Aug 2001 | - | $3.97 M(+280.8%) |
| May 2001 | - | $1.04 M(+31.9%) |
| Feb 2001 | - | $790.70 K(-28.3%) |
| Nov 2000 | $1.10 M(+47.7%) | $1.10 M(+72.5%) |
| Aug 2000 | - | $639.60 K(-12.9%) |
| May 2000 | - | $734.10 K(+33.2%) |
| Feb 2000 | - | $551.30 K(-26.2%) |
| Nov 1999 | $747.00 K(-36.3%) | $747.00 K(+1.5%) |
| Aug 1999 | - | $736.00 K(-9.6%) |
| May 1999 | - | $813.80 K(-18.2%) |
| Feb 1999 | - | $994.40 K |
| Nov 1998 | $1.17 M | - |
FAQ
- What is Aurinia Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual accounts payable year-on-year change?
- What is Aurinia Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly accounts payable year-on-year change?
What is Aurinia Pharmaceuticals annual accounts payable?
The current annual accounts payable of AUPH is $4.33 M
What is the all time high annual accounts payable for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual accounts payable is $5.10 M
What is Aurinia Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AUPH annual accounts payable has changed by +$1.24 M (+40.17%)
What is Aurinia Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AUPH is $8.88 M
What is the all time high quarterly accounts payable for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly accounts payable is $8.88 M
What is Aurinia Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AUPH quarterly accounts payable has changed by +$463.00 K (+5.50%)